Author Contributions: Dr Moses-Kolko had full
access to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Study concept and design: Moses-Kolko, Wisner.
Acquisition of data: Moses-Kolko, Bogen, Bregar.
Analysis and interpretation of data: Moses-Kolko,
Bogen, Perel, Bregar, Uhl, Levin, Wisner.
Drafting of the manuscript: Moses-Kolko, Bregar,
Critical revision of the manuscript for important
intellectual content: Moses-Kolko, Bogen, Perel, Uhl, Levin, Wisner.
Statistical analysis: Moses-Kolko, Wisner.
Administrative, technical, or material support: Moses-Kolko, Bogen, Perel, Bregar, Uhl, Wisner.
Study supervision: Wisner.
Financial Disclosures: Drs Moses-Kolko and
Wisner have received grant funding from Pfizer. Dr Perel is a consultant for
GlaxoSmithKline, Becton-Dickinson, Abbott, and Forest Laboratories. Dr Wisner
is on the speaker’s bureau for Pfizer, GlaxoSmithKline, and Shire. None
of the other authors reported disclosures.
Funding/Support: Drs Moses-Kolko, Bogen, Perel,
and Wisner were supported by National Institute of Mental Health (NIMH) grant
K23 MH 064561, National Institute of Child Health and Human Development grant
K12 HD43441-01, NIMH grant MH 30915, and NIMH grant MH R01 60335, respectively.
Role of the Sponsor: The sponsor had no role
in the design and conduct of the study, in the collection, analysis, and interpretation
of the data, or in the preparation, review, or approval of the manuscript.
Disclaimer: Drs Levin and Uhl are with the
FDA. However, their contribution to this article was made in their private
capacity. No support or endorsement by the FDA is intended or should be inferred.
Acknowledgment: We thank Ursula Bailer, MD,
and Andrea Fagiolini, MD, for their assistance with translation; Barbara H.
Hanusa, PhD, for statistical consultation; See Wei Chan, MD, for her thoughtful
comments; and Andrea Confer, BA, for her technical assistance in the preparation
of an early version of the manuscript.